GNLX

GENELUX CORPORATION

GNLX·36870H103·US·Common Stock·Healthcare - Biotechnology-13D/G

GNLX (GENELUX CORPORATION) is held by 36 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.1M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M), BlackRock, Inc. ($982,210). Net institutional sentiment: Mixed.

36
Holders
(1 Elite)
$10.6M
Total Value
41% (41)
Consensus
17 buying - 24 selling
13F: Insider & Congress:
GNLX

Smart Money Verdict

View all
Held by 36 funds
1 elite

Who's Trading

InsiderZTZindrick ThomasSell $8KMay 11, 2026
InsiderCJCappello JosephSell $2KMay 11, 2026
InsiderYYYu YongSell $2KMay 11, 2026
InsiderSRSmalling RalphSell $804.49May 11, 2026
InsiderSRSmalling RalphSell $602.4Mar 25, 2026
InsiderZTZindrick ThomasSell $9KMar 24, 2026
InsiderCJCappello JosephSell $2KMar 24, 2026
InsiderYYYu YongSell $2KMar 24, 2026
ActivistASAladar Szalay8.2%Feb 17, 2026
ActivistARArmistice Capital, LLC10.0%Nov 14, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.7M$4.1M0.0%+3.10%
37
Increased
453,761(+19.0%)$1.1M0.0%-79.68%
30
Increased
405,872(+5.3%)$982,2100.0%-1.14%
18
Decreased
323,865(-3.6%)$783,7530.0%-4.29%
0
New
251,610$608,8960.0%+3.10%
34
Increased
164,456(+15.1%)$397,9840.0%-73.30%
27
Unchanged
145,850$352,9570.0%-68.41%
0
Increased
139,041(+3.5%)$336,4790.0%-66.41%
24
Increased
122,579(+158.8%)$296,6410.0%-25.41%
26
Increased
119,008(+8.2%)$287,9980.0%-12.74%
25
Decreased
88,048(-4.5%)$213,0760.0%-14.71%
0
Decreased
61,980(-71.3%)$149,9920.0%-38.40%
0
Increased
45,572(+4.0%)$110,2840.0%+5.98%
23
Increased
41,000(+10.8%)$105,3700.0%-36.19%
24
Unchanged
37,735$91,3190.0%-38.71%
0
Decreased
32,756(-60.4%)$79,2690.0%-38.71%
0
Decreased
32,610(-82.3%)$78,9160.0%-37.09%
0
Unchanged
30,758$74,4350.0%-3.36%
0
New
27,866$67,4360.0%+3.10%
29
Unchanged
25,000$60,5000.0%-13.64%
0

Showing 1-20 of 49

1 / 3
GNLXGNLXGENELUX CORPORATION

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used